Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Update on noninvasive imaging of right ventricle dysfunction in pulmonary hypertension CARDIOVASCULAR DIAGNOSIS AND THERAPY Truong, U., Meinel, K., Haddad, F., Koestenberger, M., Carlsen, J., Ivy, D., Jone, P. 2020; 10 (5): 1604–24

Abstract

Pulmonary hypertension (PH) is a progressive disease affecting patients across the life span. The pathophysiology primarily involves the pulmonary vasculature and right ventricle (RV), but eventually affects the left ventricular (LV) function as well. Safe, accurate imaging modalities are critical for diagnosis, serial monitoring, and tailored therapy. While cardiac catheterization remains the conventional modality for establishing diagnosis and serial monitoring, noninvasive imaging has gained considerable momentum in providing accurate assessment of the entire RV-pulmonary axis. In this state-of-the-art review, we will discuss the most recent developments in echocardiography, magnetic resonance imaging, and computed tomography in PH evaluation from pediatric to adult population.

View details for DOI 10.21037/cdt-20-272

View details for Web of Science ID 000582467900037

View details for PubMedID 33224776

View details for PubMedCentralID PMC7666960